R
Roquefort Therapeutics PLC
LSE:ROQ
Roquefort Therapeutics PLC
LSE:ROQ
Price:
9.25
GBX
Market Closed
Market Cap:
£15.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Roquefort Therapeutics PLC
LSE:ROQ
|
UK |
|
SIG Group AG
OTC:SCBGF
|
CH |
|
O
|
ORION Holdings Corp
KRX:001800
|
KR |
|
Monami Co Ltd
KRX:005360
|
KR |
|
I
|
ImmunoGen Inc
XETRA:IMU
|
US |
|
A
|
AnGes Inc
OTC:AMGXF
|
JP |
|
U
|
Unifiedpost Group SA
XBRU:UPG
|
BE |
|
Brouwerij - Handelsmaatschappij NV
XBRU:COBH
|
BE |
|
H
|
Hiroca Holdings Ltd
TWSE:1338
|
CN |
|
K
|
Keynote Financial Services Ltd
NSE:KEYFINSERV
|
IN |
|
Metalurgica Gerdau SA
BOVESPA:GOAU4
|
BR |
|
Lion Metal Works Tbk PT
IDX:LION
|
ID |
|
Dole PLC
NYSE:DOLE
|
IE |
|
Lakeland Industries Inc
NASDAQ:LAKE
|
US |
|
C
|
Cibus Inc
NASDAQ:CBUS
|
US |
|
Coca-Cola Consolidated Inc
NASDAQ:COKE
|
US |
|
Eole Inc
TSE:2334
|
JP |
|
A
|
Asset World Corp PCL
SET:AWC
|
TH |
|
Southwest Gas Holdings Inc
NYSE:SWX
|
US |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
CN |
|
Suzuki Co Ltd
TSE:6785
|
JP |
|
M
|
Metalurgica Gerdau SA
BOVESPA:GOAU3
|
BR |
|
T
|
Toyo Shutter Co Ltd
TSE:5936
|
JP |
|
aTyr Pharma Inc
NASDAQ:ATYR
|
US |
Multiples-Based Value
The Multiples-Based Value for Roquefort Therapeutics PLC (ROQ) under the Base Case is hidden GBX. Compared with the current market price of 9.25 GBX, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ROQ Multiples-Based Value
LOCKED
Multiples Across Competitors
ROQ Competitors Multiples
Roquefort Therapeutics PLC Competitors
Roquefort Therapeutics PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
R
|
Roquefort Therapeutics PLC
LSE:ROQ
|
14.6m GBP | 0 | -15 | -14.3 | -14.2 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
220.3B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
97.2B ZAR | 5.6 | 10.4 | 14.2 | 14.2 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
64.8B USD | 0 | 36 637.9 | -17 156 | -17 156 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.1B CHF | 0 | 0 | 0 | 0 | |
| US |
I
|
Inspire Veterinary Partners Inc
NASDAQ:IVP
|
35.7B USD | 2 292.9 | -2 987.7 | -4 614.9 | -3 979.7 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
34.7B USD | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
29B EUR | 1 | 162.2 | 29.3 | 61.4 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
28.5B USD | 13.1 | -2 876.4 | -3 779.1 | -607.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
